These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 16860865)
41. Soluble HLA-G in rheumatoid arthritis. Verbruggen LA; Rebmann V; Demanet C; De Cock S; Grosse-Wilde H Hum Immunol; 2006 Aug; 67(8):561-7. PubMed ID: 16916651 [TBL] [Abstract][Full Text] [Related]
42. Soluble Fas in the serum of patients with non-Hodgkin's lymphoma: higher concentrations in angioimmunoblastic T-cell lymphoma. Yufu Y; Choi I; Hirase N; Tokoro A; Noguchi Y; Goto T; Uike N; Kozuru M Am J Hematol; 1998 Aug; 58(4):334-6. PubMed ID: 9692400 [TBL] [Abstract][Full Text] [Related]
43. Soluble HLA-I-mediated secretion of TGF-beta1 by human NK cells and consequent down-regulation of anti-tumor cytolytic activity. Ghio M; Contini P; Negrini S; Boero S; Musso A; Poggi A Eur J Immunol; 2009 Dec; 39(12):3459-68. PubMed ID: 19830740 [TBL] [Abstract][Full Text] [Related]
44. A study of soluble HLA-G1 protecting porcine endothelial cells against human natural killer cell-mediated cytotoxicity. Zeng MH; Fang CY; Wang SS; Zhu M; Xie L; Li R; Wang L; Wu XW; Chen S Transplant Proc; 2006 Dec; 38(10):3312-4. PubMed ID: 17175258 [TBL] [Abstract][Full Text] [Related]
45. Relationship between soluble HLA-G and HLA-A,-B,-C serum levels, and interferon-gamma production after sublingual immunotherapy in patients with allergic rhinitis. Ciprandi G; Continia P; Fenoglio D; Sormani MP; Negrini S; Puppo F; Indiveri F Hum Immunol; 2008 Jul; 69(7):409-13. PubMed ID: 18573288 [TBL] [Abstract][Full Text] [Related]
46. Natural killer activity and NK cytotoxic factors in peripheral blood and lymph node cells from non-Hodgkin's lymphoma patients. Nadkarni JJ; Mehta BA; Koppikar SB; Soman CS; Shrikhande SS; Advani SH Neoplasma; 1989; 36(6):701-8. PubMed ID: 2615873 [TBL] [Abstract][Full Text] [Related]
47. Soluble HLA class I molecules/CD8 ligation trigger apoptosis of CD8+ cells by Fas/Fas-ligand interaction. Puppo F; Contini P; Ghio M; Indiveri F ScientificWorldJournal; 2002 Feb; 2():421-3. PubMed ID: 12806026 [TBL] [Abstract][Full Text] [Related]
48. Serum levels of cytokines and prevalence of autoantibodies in lymphoma patients and their prognostic value. Uskudar Teke H; Gulbas Z; Bal C J BUON; 2014; 19(1):191-7. PubMed ID: 24659663 [TBL] [Abstract][Full Text] [Related]
49. Soluble HLA-G and HLA-A,-B,-C serum levels in patients with allergic rhinitis. Ciprandi G; Colombo BM; Contini P; Cagnati P; Pistorio A; Puppo F; Murdaca G Allergy; 2008 Oct; 63(10):1335-8. PubMed ID: 18782112 [TBL] [Abstract][Full Text] [Related]
50. In vitro effects of solubilized HLA-DR--role in immunoregulation? Claus R; Hausmann S; Zavazava N; Walzel H; Schulze HA; Köhler H; Friemel H; Müller-Ruchholtz W Cell Immunol; 1994 May; 155(2):476-85. PubMed ID: 8181077 [TBL] [Abstract][Full Text] [Related]
51. The effect of peripheral blood lymphocyte stimulation on zeta chain expression and IL-2 production in Hodgkin's disease. Frydecka I; Boćko D; Kosmaczewska A; Ciszak L; Morilla R Br J Cancer; 2001 May; 84(10):1339-43. PubMed ID: 11355944 [TBL] [Abstract][Full Text] [Related]
52. Clinical significance of elevated antinuclear antibody test in patients with Hodgkin's and Non-Hodgkin's lymphoma: a single center experience. Altintas A; Cil T; Pasa S; Danis R; Kilinc I; Ayyildiz O; Muftuoglu E Minerva Med; 2008 Feb; 99(1):7-14. PubMed ID: 18299692 [TBL] [Abstract][Full Text] [Related]
53. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas. Miettinen M Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642 [TBL] [Abstract][Full Text] [Related]
54. HLA antigens on human peripheral lymphocytes and spleen of malignant lymphoma and other cancer patients. Cohen E; Kim U; Blumenson L; Gregory SG; Khurana U; Cox C Prog Clin Biol Res; 1977; 16():181-6. PubMed ID: 269456 [No Abstract] [Full Text] [Related]
55. Differences in the soluble HLA-G blood serum concentration levels in patients with ovarian cancer and ovarian and deep endometriosis. Mach P; Blecharz P; Basta P; Marianowski P; Skret-Magierlo J; Kojs Z; Grabiec M; Wicherek L Am J Reprod Immunol; 2010 May; 63(5):387-95. PubMed ID: 20146732 [TBL] [Abstract][Full Text] [Related]
56. Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study. Ruco LP; Pomponi D; Pigott R; Stoppacciaro A; Monardo F; Uccini S; Boraschi D; Tagliabue A; Santoni A; Dejana E Am J Pathol; 1990 Nov; 137(5):1163-71. PubMed ID: 1700619 [TBL] [Abstract][Full Text] [Related]
57. HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin's lymphoma. Diepstra A; Poppema S; Boot M; Visser L; Nolte IM; Niens M; Te Meerman GJ; van den Berg A Tissue Antigens; 2008 Mar; 71(3):219-26. PubMed ID: 18257895 [TBL] [Abstract][Full Text] [Related]
58. Appraisal of immune response in lymphoproliferative syndromes: a systematic review. Alvaro T; Lejeune M; Escrivá P; Pons LE; Bosch R; Jaén J; López C; Salvadó MT; de Sanjosé S Crit Rev Oncol Hematol; 2009 May; 70(2):103-13. PubMed ID: 18996025 [TBL] [Abstract][Full Text] [Related]
59. Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma. Widney D; Gundapp G; Said JW; van der Meijden M; Bonavida B; Demidem A; Trevisan C; Taylor J; Detels R; Martínez-Maza O Clin Immunol; 1999 Nov; 93(2):114-23. PubMed ID: 10527687 [TBL] [Abstract][Full Text] [Related]
60. A study of antibody formation in patients with malignant lymphomas. GELLER W J Lab Clin Med; 1953 Aug; 42(2):232-7. PubMed ID: 13069869 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]